{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:51:46Z","timestamp":1760205106972},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"Jan 2021 Vol. 38 No. 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,15]]},"DOI":"10.12788\/fp.0081","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T16:39:10Z","timestamp":1611074350000},"source":"Crossref","is-referenced-by-count":2,"title":["Long-Term Successful Treatment of Indolent Systemic Mastocytosis With Omalizumab"],"prefix":"10.12788","author":[{"given":"Samuel","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","published-online":{"date-parts":[[2021,1,15]]},"container-title":["Federal Practitioner"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/fdp03801044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T17:52:29Z","timestamp":1617040349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/fedprac\/article\/234325\/rare-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":0,"journal-issue":{"issue":"Jan 2021 Vol. 38 No. 1","published-online":{"date-parts":[[2021,1,15]]},"published-print":{"date-parts":[[2021,1,15]]}},"URL":"https:\/\/doi.org\/10.12788\/fp.0081","relation":{},"subject":[],"published":{"date-parts":[[2021,1,15]]}}}